BIOL insider filings
BIOLASE, INC — 11 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-12. Screen BIOL transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for BIOL between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — BIOLASE, INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-06-12 | 4 | Yale Kenneth P. — Director | Grant/award (A): 502,404 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | OLoughlin Kathleen T — Director | Grant/award (A): 502,404 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | Somerman Martha J. DDS, PhD — Director | Grant/award (A): 518,429 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | Summerhays Carol Gomez DDS — Director | Grant/award (A): 491,987 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | ROPER JESS — Director | Grant/award (A): 512,821 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | LORD JONATHAN T MD — Director | Grant/award (A): 721,154 (derivative) @ $0 | EDGAR |
| 2023-06-06 | 4 | Bright Jennifer — Chief Financial Officer | Grant/award (A): 58,000 (derivative) @ $0 | EDGAR |
| 2023-06-06 | 4/A | Bright Jennifer — Chief Financial Officer | Grant/award (A): 58,000 (derivative) @ $0 | EDGAR |
| 2023-06-06 | 4 | Sandor Steven — Chief Operating Officer | Grant/award (A): 58,000 (derivative) @ $0 | EDGAR |
| 2023-06-06 | 4 | BEAVER JOHN R — President & CEO, Director | Grant/award (A): 486,255 (derivative) @ $0 | EDGAR |
| 2023-05-26 | 4 | Schuler Education Foundation — 10% owner | Purchase (P): 1,307,931 @ $0.61 · Sale (S): 1,847,649 @ $0.55 · Sale (S): 2,137,559 @ $0.54 · Sale (S): 1,733,836 @ $0.55 · Conversion (C): 3,745,000 @ $0.40 · Sale (S): 71,100 @ $0.30 · +9 more | EDGAR |
Recent 8-K events — BIOLASE, INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-10-08 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-10-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.03 — Bankruptcy or Receivership 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-09-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-08-28 | 8-K | 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement | EDGAR |
| 2024-08-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-07-22 | 8-K | 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-06-18 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-17 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-06 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BIOL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →